Strategy for dual production of bioethanol and D-psicose as value-added products from cruciferous vegetable residue
Can Glutathione IV Therapy be Combined with Other IV Drips or IM shots
Retaining 3 body mass index (BMI) units during two years between births increases the risk of adverse maternal and infant outcomes
A focus on empowering women to take control of their health
2 By moving to proactive monitorization, the FDA aims to ensure that all promotional content represents a fair balance of risks and benefits, as required by the Federal Food, Drug, and Cosmetic Act
FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition An FDA advisory committee voted narrowly on July 23, 2026, to recommend that compounding pharmacies gain access to several popular peptide compounds, including BPC-157, KPV, TB-500, and MOTS-C, overriding explicit objections from the FDA's own career scientists and sparking an audible gasp in the meeting room when the tally was announced